Clinical Trials Browser

Active not recruiting × Interventional × ublituximab × Clear all

NCT04624633 2026-02-25

Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL

Phase 2 Active not recruiting

29 enrolled 9 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT04783415 2024-12-02

Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma

Phase 2 Active not recruiting

12 enrolled 8 charts

Lymphoma, Mantle-Cell